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Despite decades of research on necrotizing enterocolitis (NEC), no major finding has improved 
the mortality and morbidity of the disease or changed the clinical management. The exact 
pathogenesis remains unclear, but several factors such as immature intestinal immunity, 
impaired bowel microcirculation, enteral nutrition and abnormal microbiota may play 
important roles. In the post-surfactant era, the NEC patient population has changed, with an 
increasing proportion of extremely preterm infants. Plain abdominal radiography is still 
considered the gold standard imaging technique for NEC. Unfortunately, abdominal 
radiography has low sensitivity and specificity, making the decision to intervene surgically 
very challenging. Recent studies have shown the increasing role of abdominal ultrasound and 
near-infrared spectroscopy in the diagnosis and monitoring of NEC. The overall aim of this 
project was to describe the preterm infants at risk of NEC and how those who develop severe 
NEC and need surgical treatment could be identified early, using new imaging techniques and 
monitoring.  
The aim of Paper I was to describe the difference in the clinical and radiological presentation 
of NEC in extremely preterm infants compared with more mature ones. Extremely preterm 
infants show less typical signs of NEC, such as bloody stool or pneumatosis intestinalis, 
compared with more mature neonates. 
The aim of Paper II was to assess if splanchnic oxygenation, as measured by near infrared 
spectroscopy (NIRS), in the first week of life is associated with the risk of developing 
necrotizing enterocolitis. Extremely preterm infants underwent NIRS monitoring during 
enteral nutrition. Low mean splanchnic oxygenation, below 30%, was associated with an 
increased risk of developing necrotizing enterocolitis during enteral nutrition in the first days 
of life. 
The aim of Paper III was to determine whether a correlation exists between the sonographic 
findings and the clinical outcomes, defined as surgery or death in infants with NEC. Infants 
with a confirmed diagnosis of NEC, who underwent an abdominal ultrasound, were included 
in the study. The sonographic sign of complex fluid collections appeared to be strongly 
correlated with the need for surgery in infants with severe NEC. 
The aim of Paper IV was to assess if hyponatremia, or worsening of already present 
hyponatremia, at the onset of necrotizing enterocolitis is associated with intestinal 
inflammation and ischaemia requiring surgery or death. In this cohort study, neonates with a 
confirmed diagnosis of NEC were included. Hyponatremia and a sudden decrease in plasma 
sodium concentration at the onset of NEC can be useful markers for severe intestinal 
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Necrotizing enterocolitis (NEC) is one of the most devastating gastrointestinal diseases among 
preterm neonates (1). The exact pathogenesis is still unclear. Despite decades of extensive 
research and experience in treating NEC patients, the disease remains a major cause of 
mortality and long-term morbidity among the most preterm infants (2-7).  
The clinical presentation of NEC varies from a purely medical condition to a life-threatening 
event entailing an urgent surgical intervention, but the decision to operate is not easy. 
Even though the first reports of what might have been NEC appeared in the early 20th century 
(8), necrotizing enterocolitis was not described as a clinical entity until the 1960s (7, 9, 10). At 
that time, most of the patients were full-term or near-term infants. In 1978, Bell et al published 
a severity staging system for NEC (11), which is, after a modification in 1986 (12), still in use 
today. The Bell staging system, based on clinical and radiological findings, is a support for 
therapeutic choices and indications for surgery. In the pre-surfactant era, NEC patients were 
mostly preterm neonates born after 30 weeks of gestation (13). Due to the improved survival 
of extremely preterm neonates, the incidence of NEC has increased over the last decades (14) 
and the patient population has now changed.  
It has been difficult to define NEC over time. Different entities of neonatal gastrointestinal 
diseases, such as spontaneous intestinal perforation, have been included in NEC datasets, 
thus contaminating them. Over time, it has become increasingly clear that NEC is actually 
more than one single disease (15). Gordon described this in one of his lectures: “NEC is a 
common pathologic end point (10), but the disease arises from multiple triggers and etiologies, 
often requiring more than one such event to meet the threshold of disease” (16). This is one 
reason why there is still no specific biomarker for NEC, despite intensive research in the field. 
This thesis describes the clinical and radiological characteristics of NEC patients, assesses the 
risk of developing NEC by using near infrared spectroscopy in extremely preterm infants and, 
finally, analyzes the correlation between surgical NEC, ultrasound findings, and hyponatremia 












NEC is a gastrointestinal inflammatory disease that mostly affects preterm neonates (2). Even 
though NEC is internationally widespread, the incidence rate varies remarkably across 
countries (17). For example, the incidence is between 7-10 in 10,000 live births in the USA 
(18, 19), while the overall incidence of NEC in Sweden was 3.4 in 10,000 live births during 
the period 1987-2009 (14). NEC occurs in 2-7% of infants born at less than 32 weeks of 
gestation in high income countries, with an incidence that varies from 5 to 22% among infants 
<1000g (17). The Swedish National Extremely Preterm Infants Study (EXPRESS) reported an 
increasing incidence from 6% in 2004-2007 to 10% in 2014-2016 among infants born before 
week 27 (20), probably due to improved early survival among the smallest infants. The same 
pattern has been seen in the Netherlands after the introduction of the new Dutch guidelines for 
the active treatment of extremely preterm infants (21). In a Canadian study, the reported 
incidence was 5.1% in infants below 33 weeks of gestation (22). It is known that NEC mainly 
affects preterm infants (8, 19), but the exact proportion also seems to vary across countries and 
over time (14, 19). In Sweden, the proportion of term infants decreased between 1987 and 2009 
from 30% to 14% (14). Both incidence and case fatality rates increase with decreasing birth 
weight and gestational age (1, 23). The onset of disease often occurs between 27 and 34 weeks 
of gestation, with the highest incidence (13%) among extremely low birth weight infants (1, 
8). The majority of NEC cases occurs sporadically, but “NEC outbreaks“ or “NEC clusters” 
have been reported, where a common etiology has been suggested (24, 25).  
2.1.1 Risk and protective factors 
Many risk factors have been shown to be related to NEC, but there is no general consensus 
among experts. Only three risk factors are universally accepted: gestational age, birth weight 
and enteral nutrition (formula) (26). Low gestational age and birth weight have been well 
studied as major risk factors for NEC (27, 28). Even though most cases of NEC occur among 
preterm infants, there is a small group of term (or late preterm) newborns who show a NEC-
like clinical status, usually in association with other conditions (such as congenital heart 
disease, gastroschisis, etc.) (29). 
The protective effect of breast milk, known for decades and confirmed by several randomized 
controlled trials, seems to be dose-related (30-33). Human milk includes a great diversity of 
beneficial bioactive factors and, among these, several have been indicated as protective 
factors, reducing both NEC incidence and progression (1). The intestinal immaturity and 
clinical instability of extremely preterm infants have always concerned clinicians, who often 
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delay the start of enteral feeding or advanced enteral nutrition at slow rates in order to protect 
the intestine. Neither early enteral fasting nor a slower advancement of enteral nutrition has 
been shown to reduce the risk of NEC, but most of these studies do not include the first days 
of life (34, 35). There are contradictory results concerning many other factors associated with 
NEC, most of which are selected from meta-analyses based solely on observational studies 









































Suggested factors associated with NEC 
 Maternal or antenatal Pre-eclampsia (risk) (37) 
Antenatal steroids (protective) (38) 
Chorioamnionitis (risk) (39) 
Premature prolonged rupture of membranes (risk) (36) 
Maternal antibiotics (protective?) (40) 
Intrauterine growth restriction (risk) (41, 42) 
Infant baseline characteristics Low gestational age (risk)  (27, 28, 43, 44) 
Low birth weight (risk)  (27, 28, 43, 44) 
Small for gestational age (risk)  (41, 43, 45) 
Congenital heart disease (risk) (43, 46, 47) 
Low APGAR/asphyxia (risk) (48) 
Postnatal Surfactant (risk) (45, 49, 50) 
Patent ductus arteriosus and treatment (risk) (43, 50, 51) 
Sepsis (risk) (50) 
Antibiotics (risk) (52) 
Severe anemia/red blood cell transfusion (risk) (53, 54) 
Fluid restriction (protective) (55) 
Feeding Breast milk (protective) (31, 32) 
Preterm formula (risk) (31, 32, 56) 
Donor human milk (protective) (57) 
Feeding protocol (protective) (58) 
Probiotics (protective) (59, 60) 
Acid suppression (risk) (61, 62) 
 




2.2 PATHOPHYSIOLOGY  
The pathogenesis of NEC has been extensively studied, but is still not clear. NEC is 
characterized by various degrees of mucosal or transmural inflammation and necrosis of the 
neonatal bowel, ultimately leading to bowel perforation, peritonitis and death (2, 63). The 
modern understanding is that necrosis of the intestinal mucosa is the ultimate endpoint of 
different triggers, which results in the diversity of clinical NEC presentations. There are some 
basic pre-conditions for developing NEC: 1) a recently colonized and naïve neonatal bowel; 2) 
a trigger that harms the intestinal mucosal integrity; and 3) the presence of food, substrate for 
bacteria, in the bowel (64). This chapter focuses mainly on the pathophysiology of the preterm 
NEC and only briefly on term/ischemic NEC that often develops in infants with underlying 
conditions (46).  
2.2.1 Preterm NEC 
The preterm bowel is more prone to develop NEC than the full-term bowel. This is explained 
by differences in bacterial colonization, microcirculatory perfusion, and maturity of the enteric 
immune system (1, 65). Each of these factors cannot explain the pathogenesis of NEC by itself, 
hence it is probably multifactorial. (Figure 1) 
 
Figure 1: Pathogenesis of preterm NEC 
2.2.1.1 Immunity 
Until enteral nutrition is effectively established, the neonatal intestine depends mainly on the 
innate system for its immunity. In this developing phase, toll-like receptors survey the lumen 
for macromolecules specific to pathogens (64). Nino et al (1) recently suggested a unified 
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hypothesis on the pathogenesis of preterm NEC, where the preterm bowel exists in a “hyper-
reactive state” compared with the full-term bowel. This benefits the development of the disease 
after colonization with an appropriate microbial flora. The fetal bowel matures in an 
environment with reduced exposure to bacteria, but preterm infants are later exposed to a 
great quantity and diversity of microbes, especially after enteral feeding is initiated (30). 
Evidence suggests that an increased baseline reactivity of the preterm intestine to microbial 
ligands, predisposes the preterm infant to an increased risk of gastrointestinal damage. In fact, 
toll-like receptor 4 (TLR4) has been shown to be more expressed in the premature bowel than 
in the full-term bowel in both animals and humans (66). TLR4 activation by gram-negative 
bacteria leads to inflammatory cytokine production, increased enterocyte apoptosis, reduction 
of enterocyte proliferation, impaired mucosal healing and reduction in intestinal blood flow (1, 
64, 67). The deleterious consequences of TLR4 activation can be the development of NEC. 
This explanation is called “the cross-switching hypothesis“ and partially explains why NEC 
occurs upon bacterial colonization in the premature infant (1).  
2.2.1.2 The gut microbiota  
Although the exact role of the intestinal microbiota in the development of NEC is uncertain, 
numerous factors implicate its involvement. The bowel colonization in the early neonatal 
period occurs in two waves: the first depending mainly on the delivery mode, the second on 
feeding type (68). In premature infants, the second wave is less influenced by feeding type 
and seems to follow a specific rate and pattern, related mostly to the degree of prematurity. 
In more premature infants, the advancement of bacterial colonization is slower but the same 
pattern of colonization is still followed (1). Many authors have shown an association between 
dysbiosis in preterm newborns and NEC development beyond three weeks of postnatal age 
(69, 70). Microbial colonization of the bowel is essential for the development of NEC, as 
NEC occurs just after this event and not in utero (69-71). However, diverse organisms are 
grown from isolated outbreaks so it cannot be claimed that a single and specific organism is 
responsible for the development of the disease, even though gram-negative bacteria are still 
the key suspects (30, 72). The use of prophylactic antibiotics in premature infants suppresses 
the intestinal flora and is associated with lower proportions of potentially protective 
anaerobes, which is a risk factor for NEC (70). Several studies suggest a loss of microbial 
diversity to occur directly before the onset of NEC (73, 74). 
2.2.1.3 Microcirculation  
Ischemia and the impairment of splanchnic microcirculation definitely play a role in the 
pathogenesis of NEC. Experimental and animal studies have suggested that an impairment in 
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intestinal microcirculation could be present in NEC patients (75). Immature intestinal 
perfusion, with a less pronounced vasodilatory response and an increased oxygen extraction to 
systemic stress, has been shown in fetuses and newborn animals compared with older ones (76, 
77). In healthy subjects, digestion and absorption of food cause an increased intestinal 
perfusion response to the increase in oxygen demand, which is called postprandial hyperemia 
(78, 79). As a result of intestinal immaturity, splanchnic microcirculation is not fully capable 
of increasing intestinal perfusion in response to an increased metabolic demand, such as during 
feeding. In fact, during the first days of life, as opposed to an intestine older than two weeks, 
the neonatal intestine compensates for different stress factors mainly with increased oxygen 
extraction rather than with vasodilation (76, 77). Studies in neonatal pups have shown that 
feeding-induced bowel hypoxia is associated with poor postprandial intestinal hyperemia in 
the first days of life (56). 
The intestinal blood flow is mainly regulated by the vasodilator nitric oxide (NO) and the 
vasoconstrictor endothelin-1 (ET-1), both produced by endothelium (75). As previously 
discussed, the preterm bowel expresses high levels of TLR4. Studies have shown that 
deletion of TLR4 in the endothelium of the intestinal cells increases NO-dependent 
microcirculation and decreases both the incidence and severity of NEC (67). Accordingly, 
studies on intestinal perfusion measured by near infrared spectroscopy have reported that 
splanchnic oxygenation is somehow impaired before the onset of NEC in preterm infants (80, 
81).  
2.2.1.4 Other factors 
Other factors that predispose the preterm bowel to NEC are immature motility, digestion, 
absorption and barrier function (30). Gastric acid secretion is reduced in the preterm neonate 
and this limitation has been related to an increased risk of NEC. Furthermore, the decreased 
number of mucus-producing goblet cells in the preterm bowel and the reduced clearance of 
intraluminal contents result in an impaired mucosal protection that leads to an augmented 
exposure to pathogenic bacteria (1, 64, 66). 
2.2.2 Enteral feeding  
As already mentioned, enteral nutrition is implicated in the pathogenesis of NEC. In fact, 
almost all premature infants who develop NEC have already been fed (64, 82-84). The start 
of enteral nutrition results in colonization of the bowel and increased food amounts lead to 
an increased oxygen demand in the splanchnic perfusion (68, 78, 79). In the past, an early 
introduction of enteral feeding to a preterm intestine, as well as increasing enteral nutrition 
too fast, has been thought to increase the risk of NEC. A recent randomized control trial 
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comparing a slow and fast rate of feeding advancement showed no evidence of an increased 
risk of NEC, but the first days of life were not included in the trial (35). Neither an early nor 
late introduction of enteral nutrition has been shown to decrease the incidence of NEC (85). 
The type of feeding seems to be important in the pathogenesis of NEC as breast milk has 
been shown to decrease its incidence (32, 33). There are many beneficial bioactive factors in 
breast milk, such as lactoferrin and secretory IgA, with different positive effects in the 
neonatal bowel (86). One example is the vasodilatory effect. Breast milk is much richer in 
nitrate anions, needed for the production of NO, than formula (56, 67). It has also been shown 
ex vivo that breast milk, known to have a protective effect against NEC (87), is a potent 
inhibitor of TLR4 signaling (88).  
2.2.3 Ischemic NEC (Term NEC) 
Term NEC occurs often during the first week of life and seems to follow hypoxic/ischemic 
events that lead to mesenteric bowel ischemia (64). Ischemia-reperfusion injury due to relative 
splanchnic hypoperfusion is believed to be an important factor in the pathogenesis of term 
NEC. Infants with congenital cardiac disease, with low peripheral perfusion and a 
compromised superior mesenteric artery perfusion are known to have a higher risk of NEC (89-
91). Infants who were growth restricted in utero and those with perinatal-ischemic events also 
belong to this group (13). Intrauterine growth restriction is a well-known risk factor for NEC, 
possibly caused by hypoxic-ischemic injury of the gut due to circulatory redistribution and 
alterations in intestinal microcirculation (75, 92). Hypoxic events are thought to induce TLR4 
expression de novo, as in infant rodent models where ischemic events/asphyxia are triggers for 
NEC (64).  
2.3 CLINICAL PRESENTATION AND DIAGNOSIS  
The clinical presentation of NEC can vary, from subtle signs of feeding intolerance that 
progress over many hours or days to a life-threatening condition requiring urgent surgical 
intervention. The early classical signs and symptoms of NEC are usually gastrointestinal and 
include abdominal pain and distention, feeding intolerance, increased gastric residuals or 
vomiting and bloody stools (65). Many of these signs are not specific for NEC and can occur 
in other diseases, such as neonatal sepsis or simply feeding intolerance (93, 94).  The disease 
can develop quickly resulting in abdominal wall erythema, bowel necrosis, perforation, and 
peritonitis (65). Abdominal wall erythema is highly predictive of NEC but is rarely present 
(95). Ultimately, patients may require increased ventilator and vasopressor support. The 
distinction between infants with real NEC and those with bacterial sepsis without NEC is 
important since the clinical management of these two conditions is quite different regarding 
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type of antibiotics, length of fasting, parenteral nutrition and, eventually, the need for surgery 
(96). Full-term infants who develop NEC postnatally are usually systemically ill and have a 
history of other predisposing conditions, such as birth asphyxia or congenital heart disease. 
Preterm babies are at risk of developing NEC for several weeks after birth and their disease can 
be more difficult to diagnose (97). More specifically, the gestational age at birth determines the 
window of vulnerability within which a neonate typically develops the disease (98). The 
postnatal age at which infants develop NEC is inversely correlated to gestational age (19, 93). 
Over the past few decades, the NEC patient population has changed, with an increasing 
proportion of the smallest preterm infants, and some studies have shown an effect of the 
gestational age in the clinical presentation of the disease (93, 99). 
2.3.1 Staging and diagnosis 
The clinical severity of NEC is still classified according to the modified Bell´s staging system 
from 1986 (12, 100). Bell´s staging system is based on three wide stages that include systemic 
signs, gastrointestinal symptoms or signs, and radiographic findings. In this staging system, the 
presence of intramural gas is the hallmark to confirm the diagnosis. A modification of Bell´s 
criteria is shown in Table 2. At the present, there is a lack of a comprehensive definition and 
staging of NEC (101), probably because it has become increasingly clear that NEC, rather than 
being one single disease (15), is actually a common pathologic final stage of different etiologies 
and triggers (10). Currently, the most commonly used definitions of NEC include that of the 
Vermont Oxford Network (102) and the modification of Bell’s criteria (12, 100). Another score 
system for NEC, recently proposed by Battersby et al, is gestational age-specific and based on 
a combination of clinical and radiological signs (97). They assigned 1-3 points to different 
signs, or a combination of signs, of NEC and defined a gestational age-specific cut-off score 
for the diagnosis of NEC. An important topic that has been raised over the past few years is the 
need of keeping other acquired intestinal diseases (such as spontaneous intestinal perforation 
or cow´s milk protein allergy) out of NEC datasets in order to improve data quality. This way 
of thinking is called NEC reductionism (13, 101). Both the Vermont Oxford Network staging 
system and the one suggested by Battersby et al include the presence of pneumoperitoneum in 
the diagnosis of NEC and do not efficiently exclude spontaneous intestinal perforation. The 
Bells system is still the most commonly used one but, due to a change in patient population and 
understanding of the disease, its adequacy has been questioned (13, 103). Lately, Gordon et al 
proposed the “two out of three rule” for the bedside diagnosis of preterm NEC, see Table 3 
























x 3 days 
IB- suspected Same as above Bright red blood from 
rectum 
Same as above Same as IA 
IIA- definite Same as above Same as above, plus 
absent bowel sounds 






x 7 to 10 days 




Same as above, plus 
absent bowel sounds, 
definite tenderness, 
with or without 
abdominal cellulitis or 
right lower quadrant 
mass 
Same as IIA, plus 
portal vein gas, 
with or without 
ascites 
NPO, antibiotics 
x 14 days 
IIIA- 
advanced 







Same as above, plus 




Same as IIB, plus 
ascites 
NPO, antibiotics 








Same as stage IIIA Same as IIIA Same as above, 
plus 
pneumoperitoneum 
Same as IIIA, 
plus surgery 






Table 3: Two out of three rule(101, 103) 
2.3.2 Imaging 
Without validated and specific biomarkers for NEC, imaging has always played a central role 
in the diagnosis and management of the disease. Plain abdominal radiography is still considered 
the standard method and first choice to detect and monitor NEC, despite the overall low 
sensitivity (104-106). The presence of pneumatosis intestinalis (intramural gas) or portal 
venous gas on plain abdominal radiography usually confirms the diagnosis of NEC (1, 103, 
104, 107, 108). Pneumatosis intestinalis is caused by bacterial fermentation within the bowel 
wall and is a sign of bacterial translocation (109, 110). This sign, even though transient, is 
almost always considered pathognomonic of NEC, although neonates with other intestinal 
diseases may also present with pneumatosis intestinalis (107, 111). The early diagnosis of NEC 
is indeed very difficult because of the low specificity and sensitivity of these radiological 
findings and the high inter-observer variability in the interpretation of abdominal radiographs 
(105, 109, 112). Recently, a new standardized evaluation of abdominal plain radiography has 
been proposed in order to improve diagnostic accuracy: The Duke Abdominal Assessment 
Scale (DAAS). DAAS is a scoring system based on radiological findings at the abdominal 
radiographs, where the score increases with the severity of the disease and the likelihood of 
surgical treatment, a score of 0 corresponds to a normal gas pattern and a score of 10 to 
pneumoperitoneum (113, 114). Pneumoperitoneum is a sign of intestinal perforation and, so 
far, the only universally accepted indication for laparotomy (95, 115). Unfortunately, 
pneumoperitoneum is not pathognomonic of NEC and not always present in babies with bowel 
perforation or bowel necrosis (95, 116). Lately, ultrasonography (US) has been widely 
Patients may be given a diagnosis of preterm NEC if they have abdominal distension, ileus 
and/or bloody stools and meet at least two of the criteria below: 
1- Pneumatosis intestinalis and/or portal gas by ultrasound or abdominal radiography at 
presentation. 
2- Persistent platelet consumption (<150,000 for 3 days after diagnosis). 
3- Post-menstrual age at disease onset more consistent with NEC than SIP 
Differential diagnosis:  
Exclusion: full-term infants (≥36 weeks of gestation), infants with known SIP and 




recognized to provide information that is not depicted on radiographs and it is now used to 
assess NEC (109, 117, 118). Routine US is used to detect pneumatosis intestinalis, bowel wall 
thickening/thinning, bowel wall perfusion, portal venous gas and other signs which are difficult 
to detected on abdominal radiographs (104, 109, 119). The main advantages of US are that it 
offers, at bedside, real-time images of abdominal organs, of the bowel and, eventually, of 
peritoneal fluids (104, 109, 116, 117, 119), all avoiding radiation exposure. Abdominal US 
seems to be more sensitive than plain abdominal radiographs in the detection of pneumatosis 
intestinalis at earlier stages, portal venous gas and, sometimes, even pneumoperitoneum (109). 
Faingold et al (119) showed that color Doppler US was extremely useful in assessing the 
perfusion of the intestinal wall. Unfortunately, Doppler sonography at low velocities is difficult 
to assess. Various studies have now proved that abdominal ultrasound outperforms plain 
abdominal radiology for the diagnosis and monitoring of NEC and should be part of the 
standard protocol for NEC diagnosis (103, 109, 120, 121). On the other hand, the technique is 
highly operator-dependent and has thus been difficult to implement in clinical practice (122). 
Faingold recently published a paper on the technical aspects of abdominal ultrasound that can 
help in the implementation of this technique (123). Especially in cases with complicated NEC 
where the patient´s clinical deterioration does not correspond with the radiographic picture, US 
gives more information about the viability of the bowel wall, suggesting that it is an accurate 
screening tool to determinate the need for surgical intervention (116, 119, 124-126). Research 
with contrast-enhanced US, which has the ability to evaluate the microvascular perfusion, 
might also be valuable in certain subsets of infants with NEC (127). 
2.3.3 Laboratory  
Many biomarkers to detect NEC have been assessed so far, but none of them is “ideal”. Current 
biomarkers for the clinical assessment of NEC are usually divided into non-specific and 
specific biomarkers.  
2.3.3.1 Non-specific biomarkers 
The most common non-specific biomarkers for NEC are mediators of the inflammatory 
cascade. Acute phase reactants, such as C-reactive protein (CRP) and serum amyloid A (SAA), 
are often used in the diagnosis of NEC. CRP is a “late-warning” biomarker, therefore it is not 
as useful for early diagnosis of inflammatory conditions as for monitoring the disease progress 
(128, 129). SAA is another acute phase reactant that is synthesized in response by activated 
macrophages to cytokine release after acute-phase stimuli, such as infection and tissue injury 
(130). SAA is quite similar to CRP, but has a faster upregulation, it is not specific for NEC and 
its levels are increased in both infants with NEC and sepsis (131). Platelet-activating factor 
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(PAF), an endogenous inflammatory phospholipid, has also been studied in both plasma and 
feces for NEC diagnosis/monitoring with promising results (129, 132). Other acute phase 
proteins, such as procalcitonin, have been suggested as valuable indicators for diagnosing or 
predicting surgical NEC (96). Interleukin (IL)-6 and tumor necrosis factor (TNF)-α, regulated 
upon activation of normal T-cell expression, are known to be early biomarkers for diagnosing 
both neonatal sepsis and NEC (128, 133). Some authors have reported significantly higher IL-
6 and IL-8 levels in surgical NEC than in matched controls (134). Other non-specific 
immunoregulatory mediators of the inflammatory pathway, such as neutrophil CD64, IL-6, and 
apolipoprotein CII, are early warning biomarkers, but they cannot discriminate NEC from 
sepsis and other inflammatory diseases (96, 128). Markers for metabolic derangement, such as 
acidosis, hyponatremia and thrombocytopenia have also been studied in combination as 
predictors of surgical NEC (135, 136). Thrombocytopenia is often present in NEC and has 
recently been included by Gordon as a criterion for NEC (103, 137). CRP and platelet count 
are still the most widely used biochemical markers for diagnosing and monitoring NEC (138). 
2.3.3.2 Specific biomarkers 
Organ-specific biomarkers indicate gastrointestinal mucosal injury and/or intestinal barrier 
impairment. They include intestinal fatty acid-binding protein (i-FABP), liver fatty acid-
binding protein (l-FABP), and fecal calprotectin (1). When the bowel mucosa is severely 
injured, damaged enterocytes and epithelial cells release large amounts of these intestinal 
barrier proteins into the blood. Theoretically, measuring their concentrations in serum or urine 
can allow an early diagnosis of NEC and quantify the severity of intestinal damage (139). The 
most encouraging is i-FABP, a cytoplasmatic protein released in the blood after intestinal 
damage and secreted in the urine that seems to correlate with the extent of intestinal necrosis 
(131, 140-142). Levels of l-FABP in combination with i-FABP were found to be higher in 
infants who later developed NEC compared with those who did not, suggesting that intestinal 
mucosal damage is detectable before NEC symptoms develop (131). Unfortunately, despite its 
high specificity, i-FABP has a medium-low specificity for NEC. One explanation could be that 
an elevated level of i-FABP is suggestive of mucosal damage rather than damage extending 
into the muscle layers (141, 143). Calprotectin is an antibacterial protein expressed in 
granulocytes and monocytes upon inflammatory activation that is widely used in the screening 
and monitoring of inflammatory bowel disease (129, 144). Fecal calprotectin has been 
evaluated for the diagnosis of NEC as well, and a recent metanalysis defines it as a “promising 
biomarker with high diagnostic value”, even though it remains unclear which cut off should be 
used (145). None of these bowel-specific proteins can be used as an early screening or warning 
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tool for detecting minor forms of intestinal injury (139). The latest systematic review of the 
available evidence concludes that serum markers for necrotizing enterocolitis generally have 
a low diagnostic accuracy, thence the use of many of them in clinical practice is so far 
unjustified (146). 
2.3.4 Near Infrared Spectroscopy  
Near infrared spectroscopy (NIRS) is a bedside non-invasive monitoring technique that 
measures the difference between oxyhemoglobin and deoxyhemoglobin. It measures the 
balance of oxygen that is delivered minus what is extracted at tissue level (147, 148). Biological 
tissue is quite transparent to near-infrared light (700-1000nm), which is absorbed by different 
chromophores in the bloodstream. Hemoglobin, which is the main chromophore in the 
bloodstream, absorbs NIR-light depending on its oxygenation level (148-150). NIRS 
technology generally uses wave-lengths of 700-850 nm. At these lengths oxygenated and 
deoxygenated hemoglobin have characteristic spectra (149, 151). Using a modified version of 
the Beer-Lambert equation, NIRS devices are able to measure changes in the concentration of 
oxyhemoglobin (150, 151). This noninvasive measurement is reported as the regional oxygen 
saturation (rSO2) by INVOS® devices, as well as in this thesis (147, 149). The rSO2 is a mixed 
saturation value. Since the greater proportion of blood is venous, veins account for 80-85% 
of the rSO2, while arteries provide 15%-20%, and capillaries 5% (149, 150). A low rSO2 
measurement can either reflect increased oxygen extraction at tissue level or reduced blood 
flow altering the oxygen supply in the tissue monitored. 
2.3.4.1 NIRS and NEC 
NIRS is widely used for the assessment of cerebral oxygenation (150, 152) and could 
potentially allow continuous monitoring of intestinal perfusion as well. Since bowel 
ischemia, or at least impaired intestinal perfusion, seems to be associated with the 
development of NEC (75), measuring splanchnic oxygenation  and extraction might detect 
changes compatible with the initial stages of NEC at an earlier point. Splanchnic rSO2 has 
been validated against gastric pH measurements, systemic mixed venous oxygenation, 
venous saturation from umbilical catheters, and serum lactate in neonates (153, 154). 
Splanchnic oxygenation (rSO2) seems to change with both gestational and postnatal age in 
preterm infants during the first weeks of life (155) and it is known to have a greater variability 
than cerebral rSO2. Previous studies have shown that splanchnic NIRS measurements differ 
between preterm infants with and without intestinal ischemia (156, 157). One study reported 
that by measuring both cerebral and splanchnic oxygenation it was possible to differentiate 
complicated from uncomplicated NEC (158). The ratio between splanchnic and cerebral 
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oxygenation (SCOR or CSOR depending on the authors) has also been studied and described 
as a marker for abdominal pathology or anemia in infants (156, 159). Whether splanchnic 
oxygenation can be used in prediction models for NEC is still under debate. Corvaglia et al 
used splanchnic NIRS monitoring at the first feed to predict feeding intolerance in preterm 
infants (160). Actually, animal models have shown that low splanchnic rSO2 within the first 
days of life might be a risk factor for NEC (161) and impaired intestinal oxygenation before 
the onset of clinical NEC has been  reported in preterm infants (80, 81). It remains, however, 
that NIRS monitoring has so far not proven to be helpful to distinguish between definite NEC 
and no NEC in preterm infants with clinical signs suspicious of the disease. It could possibly 
be a useful tool in identifying infants who will develop NEC and those who will have a more 
complicated course. All the studies mentioned are quite small and further studies are needed 
to understand the potential role of NIRS in intestinal perfusion and NEC (162).   
2.4 MANAGEMENT AND INDICATIONS FOR SURGERY  
The management of a suspected case of NEC consists of providing supportive care with fasting 
and administration of broad-spectrum intravenous antibiotics, after having secured blood 
cultures (2, 71). Patients are closely monitored for progression of the disease and the abdomen 
is regularly assessed using both clinical examinations and imaging (71, 138). Medical treatment 
(such as fasting and antibiotics) is continued for 7 to 14 days as long as the patient is stable and 
improving. There is no evidence of any specific antibiotic regime being superior to others (163) 
and empiric antibiotic therapy should be tailor-made according to the hospital´s antibiogram.  
Surgical treatment is needed in approximately 50% of the NEC patients in large population-
based studies (22, 164). Frank intestinal perforation, diagnosed by pneumoperitoneum on plain 
abdominal radiography or, rarely, by paracentesis positive for stool, is the only absolute 
indication for surgical treatment (115, 119, 165, 166). However, pneumoperitoneum is not 
always present in neonates with bowel perforation or necrosis, especially when the infant is 
very premature (93, 95, 116). The diagnosis of surgical NEC is not easy and the decision to 
operate is difficult considering the lack of consensus on how to manage surgical NEC (138). A 
deteriorating clinical condition (acidosis, severe persistent thrombocytopenia, hypotension) 
despite optimal medical management, or the presence of widespread pneumatosis intestinalis, 
portal venous gas, or fixed bowel loops on serial radiographs are relative indications for surgery 
(95, 136, 165, 167). Patients who need surgical intervention usually undergo explorative 
laparotomy with the goals of resecting only clearly gangrenous non-viable bowel, reducing the 
systemic sepsis and subsequent risk of multiorgan failure, and preserving any bowel that has a 
chance of survival (165). This approach focuses on bowel preservation with the intention of 
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reducing the number of patients who will later develop short bowel syndrome (137). Peritoneal 
drainage is an alternative for the most unstable patients, being used as both a temporary and a 
definite solution (138). Several studies have shown that patients undergoing peritoneal 
drainage have comparable outcomes to those undergoing laparotomy (164, 168-171). Given 
that most infants treated with peritoneal drainage require a laparotomy later on (164, 171), 
peritoneal drainage is reserved for small (<750g), unstable patients with elevated abdominal 
pressure that impairs ventilation. 
2.5 OUTCOMES  
NEC remains one of the leading causes of death in neonatal intensive care units (172). The 
overall mortality reported is around 15-30% and decreases substantially with increasing birth 
weight (3, 18, 19, 21, 30, 137). The majority of NEC cases can be managed medically, 
although approximately 20-50% of affected infants require surgery (21, 45, 173). Many 
authors report unchanged mortality rates over the last decades (21, 45). It is important to 
make a distinction between medical and surgical NEC, since surgical NEC has a much higher 
mortality rate, up to 50% in extremely low birth weight infants, and is strongly associated  
with many long-term complications (5, 137, 173, 174).  
2.5.1 Long-term outcomes 
NEC survivors are at a higher risk of developing long-term complications, some related to the 
gastrointestinal (GI) tract, others affecting general growth and neurodevelopment.   
2.5.1.1 Gastrointestinal complications  
Bowel strictures are the most common GI complications. They occur in 20% of NEC patients, 
usually after surgical NEC, but they may also develop after medical NEC (175, 176). The 
formation of strictures is caused by fibrosis of the bowel loop affected by NEC, as an attempt 
to heal after severe ischemic damage, and does not seem to depend on the surgical procedure 
as such (115, 176). 
NEC remains the most common cause of pediatric short bowel syndrome (SBS) (137, 177, 
178). Intestinal failure is defined as “the reduction of gut function below the minimum 
necessary for the absorption of macronutrients and/or water and electrolytes, such that 
intravenous supplementation is required to maintain health and/or growth” (179, 180). The 
inability to wean off parenteral nutrition results in increased mortality and additional 
complications such as risk of intestinal failure-associated liver disease and central line-
associated blood stream infections in these infants (176). A recent metanalysis reported that 
intestinal failure rates vary from 15% in all NEC to 35% in surgical NEC (174). On the bright 
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side, however, studies have shown that NEC children have a better chance of achieving enteral 
autonomy when compared with other causes of short bowel syndrome (181). This could be 
explained by considering that NEC is a disease that mainly affects very premature infants, and 
one can assume that the intestines of these neonates have better abilities to adapt over time than 
in other patients with SBS (3). Long-term growth and development may be compromised in 
NEC survivors, especially in infants with short bowel syndrome (178). Even NEC survivors 
without intestinal failure are likely to fall below the 50th percentile for weight and height 
several years later (182).  
2.5.1.2 Neurodevelopmental outcomes 
NEC survivors can develop neurodevelopmental dysfunction, including speech and motor 
impairment, intellectual delays, and problems with social skills. This occurs in up to 40-50% 
of cases in  very low birth weight infants (176, 183). Several studies have reported long-term 
neurodevelopmental impairment in neonates who survived NEC (174, 184, 185). A 
systematic review from 2007 indicates that a definite diagnosis of NEC (Bell´s stage II or 
higher) is associated with an increased risk of long-term neurodevelopmental impairment in 
very low birth weight infants (183). The risk seems to be even higher in the presence of 
surgical NEC (6, 183). No significant differences have been reported in neurodevelopmental 
outcomes between very low birth weight infants with spontaneous intestinal perforation and 
those without surgical diseases, when the influences of severe IVH (grades 3 and 4) and 
sepsis were excluded (186). 
Neurodevelopmental impairment includes, in most cases, at least one of the following: scores 
less than two standard deviations of normal on the Bayley or Griffiths scale of assessment, 
cerebral palsy, severe visual impairment and severe hearing impairment (183). In this review, 
there are two important issues that need to be discussed; the differences in definition of 
neurodevelopmental impairment and the short follow-up time in some studies. Differences 
in definition of the severity of cerebral palsy and different cut offs for psychomotor and 
cognitive impairment can over- or underestimate the impairment rates. Simon et al (187) 
reported a higher incidence of motor delays at 8 and 15 months of corrected age in very low 
birth weight neonates requiring surgery for NEC. However, in most of the cases, the motor 
delays had resolved by 24 months, underlining the importance of a longer follow-up (187). 
Since the diagnosis of definite NEC is associated with long-term neurodevelopmental 
impairment, prevention, early diagnosis, optimal management, and long-term follow-up after 
the disease are extremely important in this group of patients.  
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2.6  PREVENTION 
The protective effect of breast milk has been confirmed by several randomized controlled 
trials (30, 188). A variety of beneficial bioactive factors contained in human breast milk have 
been shown to reduce NEC incidence and progression (1). The use of probiotics to prevent 
NEC has been extensively studied. The World Health Organization define probiotics as “live 
micro-organisms, which, when administered in adequate amounts, confer a health benefit on 
the host” (189). Even if several randomized controlled trials have shown conflicting results, 
different meta-analyses have demonstrated a statistically significant positive effect of 
probiotics in both preventing NEC and reducing all-cause mortality (190-192) . Among the 
many different probiotic strains that have been tested, the European Society for Paediatric 
Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics has 
now recommended: Lactobacillus rhamnosus GG ATCC53103 or the combination of 
Bifidobacterium infantis Bb-02, Bifidobacterium lactis Bb-12, and Streptococcus 
thermophilus TH-4 (59). At the same time, there is still not enough evidence for the use of 
probiotics in infants with a birthweight of less than 1000 g (193). The use of lactoferrin 
supplementation has also been studied for the prevention of NEC. Lactoferrin seems to 
decrease late-onset sepsis but not NEC stage II or III in preterm infants (194) and so, at this 



















3 HYPOTHESIS AND AIMS 
The overall aim of this project was to describe the clinical and radiological characteristics of 
NEC patients, to assess the risk of developing NEC using NIRS in extremely preterm infants 
and, finally, to study how infants who develop severe NEC or need surgical treatment can be 
identified early, using new imaging techniques or biochemical status. 
3.1 SPECIFIC AIMS: 
1- To examine the effect of gestational age on the clinical and radiological presentation of 
NEC (Paper I). 
 
2- To study the role of NIRS as a tool to identify patients with a high risk of NEC (Paper 
II). 
 
3- To study the correlation between sonographic findings and outcomes in NEC patients 
(Paper III). 
 
4- To assess if hyponatremia, or a decrease in  plasma sodium levels, at the onset of NEC, 


























4 STUDY DESIGN AND METHODS 
4.1 STUDY DESIGN AND POPULATION 
The study design and population used in the included studies are described below and 
summarized in Table 4. 
 
Paper  Study Study design Population and setting N of 
subjects 




NEC patients treated 
in Stockholm from 1st 
January 2009 to 31st 
December 2014  
89 




infants born at the 
Karolinska University 
Hospital from 1st  
September 2014 to 
31st December 2016  
45 





NEC patients who 
underwent abdominal 
ultrasound from 
September 2010 to 




IV Hyponatremia study Retrospective cohort 
study 
NEC patients treated 
in Stockholm from 1st 
January 2009 to 31st 
December 2014  
88 




4.1.1 Papers I and IV: Population and setting 
In Papers I and IV the same study population was used. All neonates treated in Stockholm 
County Council (SLL) from 1st January 2009 to 31st December 2014 with a NEC diagnosis 
(P.779, according to ICD-10) were identified in the Swedish National Quality Register 
(SNQ). Data were recorded manually and prospectively from the medical records to validate 
the diagnosis. All infants included in the study were admitted to a NICU level II or higher, 
in community or academic settings.  Infants were included in the study if they had a verified 
NEC diagnosis (≥ Bell's stage II). If the diagnosis was uncertain, one fellow in neonatology 
and one experienced neonatologist reviewed the patients’ charts. If radiological findings were 
uncertain, the radiographs were reviewed by an experienced pediatric radiologist. Infants 
with NEC Bell´s stage < II were not considered to have NEC and were hence not included in 
the study. Patients with major abdominal malformations or with spontaneous intestinal 
perforations were also excluded (101, 170). All patients who required surgery were treated 
in the same center, the Karolinska University Hospital in Stockholm. In Paper IV, only 
patients with verified NEC combined with available data on plasma sodium at NEC onset 
were included.  
4.1.2 Paper II: Population and setting 
This was a prospective cohort study. Extremely preterm infants, born before 28 weeks of 
gestational age and admitted to the neonatal intensive care unit of the Karolinska University 
Hospital, Stockholm, from September 2014 to December 2016, were enrolled. Exclusion 
criteria were infants born before 23 weeks of gestation, major abdominal wall defects, major 
known intra-abdominal malformations and critically ill neonates who did not tolerate 
abdominal ultrasound or NIRS monitoring. The infants were included during the first six 
days of life. 
4.1.3 Paper III: Population and setting 
 In Paper III, all neonates with a verified NEC (Bell´s stage ≥ II), admitted to the Department 
of Neonatology at the Karolinska University Hospital, Stockholm, Sweden, from September 
2010 to August 2013, were identified. Only patients who underwent at least one AUS and 
plain radiography the same day were included in the study. Patients with pneumoperitoneum 






4.2 CLINICAL VARIABLES 
The demographic, clinical and radiological data, laboratory findings and histology reports were 
manually collected from medical charts. The demographic and clinical data collected were: 
gestational age, birth weight, maternal and delivery-related information, IUGR, intraventricular 
hemorrhage, patent ductus arteriosus, respiratory distress syndrome and clinical findings at 
NEC onset (increased and/or bilious aspirates, feeding intolerance, blood in stool, abdominal 
erythema, abdominal distension). The radiological data (such as gasless abdomen, portal 
venous gas, fixed loop, pneumatosis intestinalis, ileus, and pneumoperitoneum) were collected 
from reports and, when needed, images were reviewed as well. Histological reports were 
mainly from surgical specimens and autopsy. Laboratory findings included: CRP, platelets 
count, plasma lactate, plasma glucose, plasma sodium and creatinine. The clinical variables of 
main interest are listed in Table 5. 
In Paper II, the risk of NEC was the primary outcome and age at full enteral nutrition was 
our secondary outcome. In Paper III, the need for surgery and death were listed as outcomes. 
























Clinical variables Definition  Paper 
NEC diagnosis/verified 
NEC 
Bell´s stage > II, based on the presence of 
pneumatosis intestinalis on abdominal X-ray, 
visual inspection at laparotomy, and/or 
histological evidence of NEC. Infants with 
spontaneous intestinal perforation were also 
excluded.  
I-IV 
Surgical NEC/need for 
surgery 
When the neonate underwent surgical treatment, 
and/or peritoneal drainage. Used as a proxy 
parameter for bowel gangrene or perforation.  
I and III 
Age to full enteral nutrition The first day when the patient tolerated full 
enteral nutrition, without any parenteral nutrition.  
II 
Pneumoperitoneum Free gas at the abdominal radiography. I,III,IV 
Pneumatosis intestinalis Intramural gas at the abdominal radiography or at 




Absence of intraluminal gas at the abdominal 
radiography.  
I 
Bloody stools The presence of bloody stools reported in the 
medical chart. 
I 
Bilious gastric aspirates The presence of bilious gastric aspirates causing 
the withdrawal of enteral nutrition reported in the 
medical chart.  
I 
Hyponatremia A plasma sodium (P-Na) < 135 mmol/L at the 
onset of NEC. 
IV 
Difference in P-Na (ΔNa) The difference in P-Na obtained before and at 
NEC onset. 
IV 
Severe NEC  The need for intestinal resection and/or NEC-
related death within 2 weeks of the onset of NEC. 
IV 





4.3 NEAR INFRARED SPECTROSCOPY AND NIRS DATA, PAPER II 
In Paper II, NIRS technology was used for monitoring splanchnic oxygenation (SrSO2) during 
the first week of life. The hypothesis was that low splanchnic oxygenation was associated with 
a higher risk of NEC.  A single NIRS monitoring was performed at postnatal age 2 to 6 days, 
within 96 hours after the first enteral feeding. The infants included underwent an abdominal 
ultrasound to help position the sensors for splanchnic NIRS monitoring. The study protocol 
details are described in Paper II. We used an INVOS-5100c (MedtronicTM, USA) monitor 
with neonatal INVOS sensors to measure cerebral and splanchnic rSO2 (Figure 2). The 
measurements were performed for one hour. High-quality recordings for at least 20 
consecutive minutes after the baseline recording were required to be included in the analyses. 
NIRS data were analysed for periods of artefacts. Artefacts were defined as changes in rSO2 
that could not be physiologically explained (e.g., a 30% change between 2 subsequent data 
points) or missing rSO2 values because of measurement failure. Values of 15% and 95% (the 
minimum and maximum values for INVOS) from our analyses were not excluded. To 
determine whether low mean SrSO2 values predicted the onset of NEC, mean values from 
the NIRS measurements, which were obtained between 48 and 144 hours after birth, were 
used. The mean rSO2 (cerebral and splanchnic) with standard deviation was calculated for 
each measurement. The splanchnic cerebral oxygenation ratio (SCOR) was calculated as 
splanchnic oxygenation divided by cerebral oxygenation (SrSO2/CrSO2). Unless a 
documented misplacement of the sensor occurred or the measurement was shorter than 20 
minutes, all these NIRS data were included in the analysis.  Cut off for mean SrSO2 was 
based on the receiver operating characteristic curve analysis. Infants who developed verified 
NEC and those who did not develop NEC were compared for different explanatory variables. 
 
 
Figure 2: Example of cerebral (blue) and splanchnic (red) oxygen saturation in a stable extremely preterm 




4.4 ABDOMINAL ULTRASOUND, PAPER III  
In Paper III, the association between sonographic signs and outcomes (need of surgical 
intervention or death in NEC patients) was studied. All US examinations were performed 
according to our local protocol, which is based on the technique discussed by Faingold et al 
(119). All four abdominal quadrants were evaluated using vector and linear array transducers 
functioning between 8 and 15 MHz. An experienced pediatric radiologist reviewed all the 
patients’ sonograms. The US features were categorized into eight findings and are shown in 
the images below: 
• Bowel wall thickness, measured by calipers, normal values between 1.1 and 2.6 mm. 
(Figure 3) 
 
Figure 3: US images in grey scale. On the left, a bowel loop with thin bowel wall. On the right, two bowel 
loops with bowel wall measured with calipers, 1.9 mm. 
• Bowel perfusion, with a velocity setting of 0.09 m/s, was considered increased when 
there was an increased color flow signal (in a loop signal). Increased perfusion 
patterns: ring or Y or zebra patterns of flow. Evaluation was generally subjective. 
(Figure 4) 
 
Figure 4: US images, both demonstrating hyperemic bowel perfusion with zebra patterns. 
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• Bowel perfusion was considered absent when no flow was detectable within the 
bowel wall on Doppler sonography after decreasing the velocity setting. Evaluation 
was subjective, as above. (Figure 5) 
 
Figure 5: US image, bowel loop with non-detectable Doppler flow. 
• Pneumatosis intestinalis was considered to be present when there were punctuate or 
granular increased echogenic foci within the bowel wall (195). (Figure 6) 
 
Figure 6: US images in grey scale showing pneumatosis intestinalis (arrow) in the bowel wall.   
• Portal venous gas was considered present when punctuate echogenic foci were noted 
within the main portal vein or its intrahepatic branches.(Figure 7) 
 
Figure 7: US images of liver parenchyma in grey scale with portal venous gas (arrow).   
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• Anechoic free peritoneal fluid. (Figure 8) 
 
Figure 8: US images in grey scale showing bowel loops and surrounding anechoic fluid (arrow). 
• Focal fluid collections were considered complex when echogenic material or septa 
were noted. (Figure 9) 
 
Figure 9: US images in grey scale. Complex fluid collections with septa (arrow). 
• Peristalsis was assessed according to the presence or absence of bowel contractions 
on a cine sequence. 
 
4.5 STATISTICAL ANALYSIS  
4.5.1 Directed Acyclic Graph  
Directed Acyclic Graphs (DAGs) are graphs that simplify the interpretation and 
communication in causal inference and are used for covariate selection in observational studies 
(196). DAGs were used to identify possible confounders that could induce a non-causal 
association between our variable of interest Rand outcome in our cohort studies. Each arrow 
represents a causal influence.  
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In Paper II, we wanted to identify possible confounders between mean splanchnic oxygenation 
(SrSOR2)  ) and risk of NEC (Figure 10). In white are the confounders that could induce a non-
causal association between mean SrSOR2 Rand risk of NEC according to the DAG. 
 
Figure 10: The DAG for Paper II. In white are the confounders that could induce a non-causal association 
between exposure and outcome (blue) according to the DAG, (GA, gestational age; PDA, patent ductus arteriosus; 
SGA, small for gestation age; IVH, Intraventricular hemorrhages). 
 
The DAG for Paper IV is shown below (Figure 11). We wanted to identify possible 
confounders between hyponatremia at NEC onset ) Rand risk of severe NEC. In this paper we 
used a DAG to see the relationship between the variables. Hyponatremia was investigated at 
NEC onset as an intermediate step in the causal way, or biologically speaking in the 




Figure 11: The DAG for Paper IV. Severe NEC is the outcome (in blue). In white are the confounders that could 
induce a non-causal association between hyponatremia and risk of severe NEC, (P-Na, plasma sodium 
concentration). 
4.5.2 Statistical analysis  
 
Papers II and IV are designed as cohort studies where a “population at risk” is followed over 
time. The risk is, respectively, to develop NEC or severe NEC. Therefore, a measure of effect 
was chosen to present the results. Generalized linear models were applied with respectively 
log and logit link to analyse the primary outcome and presented as, respectively, the risk ratio 
of NEC and the odds ratio of severe NEC. For the secondary outcome in Paper II, age at full 
enteral nutrition, a Cox regression analysis was performed and presented as a hazard ratio 
(HR). Time had an important role in the secondary outcome of Paper II. Therefore an 
instantaneous effect measure such as HR was chosen instead of a cumulative effect measure 
such as risk ratio (RR) or odds ratio (OR). In Paper IV, a measure of effect (OR) instead of 
the accuracy of a test was presented for two reasons; firstly, the retrospective design of the 
study could easily induce selection bias, secondly it is not possible to study a continuous 
variable as such (for example plasma sodium) when presenting sensitivity and specificity.  
In all the papers, the Mann-Whitney U-test, Student's t-test and chi-square or Fisher's exact 
test were used, whenever appropriate, to compare clinical characteristics between patients 
who developed NEC and those who did not, or between infants who needed surgery or not. 
 
36 
A p-value <0.05 was considered statistically significant. The statistical program STATA 
version 14.2 (StataCorp, College Station, TX, USA) was used to perform the analyses. 
4.5.3 Sensitivity analysis 
In all four papers, the patient sample size was quite small. Because a small sample size can 
easily induce significant associations or results that are based, for instance, on a single patient 
multiple sensitivity analyses were performed, especially in Papers II and IV to test the 
robustness of our results.  
4.6 ETHICAL APPROVAL  
The ethical approval numbers are shown in Table 6. 
Paper Ethical approval number 
I 2015/2144-31/1 
II-III 2014/500-31 
IV 2017/1237-31, 2019/06289 


















5.1  THE EFFECT OF GESTATIONAL AGE IN NECROTIZING ENTEROCOLITIS 
(PAPER I)  
For Paper I, 131 medical charts and radiographic images were reviewed of infants with a 
NEC diagnosis. (Figure 12)   
 
Figure 12: Flow chart  
Eighty-nine patients (median gestational age 26.3 weeks, IQR 24.9-29) were considered to 
have verified NEC and were thus included in the study. Most of them were males (67.4%) and 
delivered by cesarean section (65%). Sixty infants were born at < 28 weeks GA and 29 infants 
were born at ≥ 28weeks GA. Fifty-seven patients underwent surgical treatment and more than 
70% of them were extremely preterm. As expected, extremely preterm infants developed more 
complications related to prematurity compared with the more mature infants, IUGR/SGA was, 
on the other hand, more common in NEC patients born at  ≥ 28 weeks of gestation. Extremely 
preterm neonates develop NEC symptoms later in life compared with more mature infants.  
Clinical and radiological data are shown in a graph (Figure 13) and with more details in tables 
in Paper I. 
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Figure 13: Clinical and radiological differences between neonates with NEC, born at < 28 weeks in purple and at 
≥ 28 weeks gestational age in blue, *= p <0.05. 
 
Bloody stools, which are considered quite a typical indication for NEC, were present in only 
20.0% of the extremely preterm infants compared with 58.6% of the more mature ones. 
Pneumatosis intestinalis was detected in only 60.0% of infants born before 28 weeks of 
gestation vs 86.2% of infants born at ≥ 28 weeks of gestation (p=0.013), while this finding was 
still significant in the subgroup of surgical NEC infants (Figure 14). The relative frequencies 
of pneumatosis intestinalis per gestational age are shown in Figure 15. Almost 48% of the 
infants (50% born at <28 weeks vs 40% born at ≥28 weeks) who required surgical intervention 
did not present pneumoperitoneum at the abdominal radiography. Extremely preterm neonates 
who required surgery more often presented with a gasless abdomen on abdominal radiographs 










Figure 14: Clinical and radiological differences between neonates with surgical NEC, born at < 28 weeks in 











5.2 LOW SPLANCHNIC OXYGENATION AND RISK OF NEC (PAPER II) 
Forty-nine infants completed the study and underwent NIRS monitoring. Forty-five patients 
had complete NIRS data. One infant developed NEC within one day of NIRS monitoring and 
was therefore excluded from the study. Forty-four patients were included in the final analysis, 
61% of the infants were male. Median gestational age was 25.6 weeks (range 23.0-27.9) and 
median birth weight 698 grams (range 485-1353), 18% of the infants were SGA. Eight infants 
developed NEC during the neonatal period at a median postnatal age of 15 days (range 6-35 
days) and six of them required surgery. The mean age at full enteral nutrition was 11.7 
± 4.6 days. We defined a cut off of 30% for SrSO2 which was supported by the receiver 
operating characteristic curve analysis, shown in Figure 16. 
 
Figure 16: Receiver operating characteristic curve for splanchnic oxygenation (SrSO2) and risk of NEC. AUC= 
area under the ROC curve 
Sixteen infants had a mean SrSO2 < 30% in total: 75.0% of the infants who developed NEC vs 
27.8% of the infants who did not (p=0.019).  All infants who developed surgical NEC had a 
mean SrSO2 <30%. There was no difference in median SrSO2, CrSO2 or SCOR between the 
two groups. The risk ratio to develop NEC was assessed using a generalized linear model 
analysis, with NEC as the dependent variable. Infants with a mean SrSO2 < 30% had a higher 
risk of developing NEC compared with those with a mean SrSO2 >30% (Crude RR 5.25, 95% 
CI 1.19-23.01). Adjusted risk ratios for gestational age, birth weight, SGA, days at NIRS 
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monitoring, passed stool and CrSO2, still showed a significant positive association between 
SrSO2 < 30% and NEC. 
Since all infants who developed NEC had obtained more than 60 ml/kg/d of enteral feeds, a 
sub-analysis in this subgroup was performed showing that infants with a mean SrSO2 < 30% 
had a still higher risk of developing NEC compared with those with SrSO2 > 30% (Crude RR 
6.00, 95% CI 1.61-22.42).    
No statistically significant association was seen between age at full enteral nutrition and SrSO2 
(HR 1.05, 95% CI 0.57-1.96), even when adjusted for gestational age or presence of a patent 
ductus. A sub-analysis excluding infants born at a gestational age of 26 and 27 weeks was 
performed showing that the risk of NEC was still significantly higher in infants with a mean 
SrSO2  < 30%, but no correlation was found between age at full enteral nutrition and SrSO2. 
5.3 ABDOMINAL ULTRASOUND AND NEED FOR SURGERY (PAPER III)  
Thirty-six out of 58 screened patients (62%) with a verified diagnosis of NEC underwent 
AUS and plain abdominal radiography on the same day. Eleven patients were excluded; five 
because of missing data and six because they developed free gas, thus presenting an absolute 
indication for surgery. Twenty-five patients, with a median gestational age of 25.6 (range 23-
35) weeks were included in the study, 72% of them were male. Eleven patients underwent 
surgery and five patients died (only one of which did not undergo NEC surgery). We did not 
find any association between surgery and bowel wall thickness, absent peristalsis, free fluids, 
increased or absent bowel flow and intramural or portal gas. Absent flow at Doppler 
sonography and portal gas were actually only present in infants who required surgery. Only 
the sonographic finding of complex fluid collections was more frequently present in infants 
who underwent surgery compared with those who did not (7.14% vs 63.6%, p=0.007).  There 
was no significant difference between NEC survivors and those who died in any of the 
sonographic findings studied. 
5.4 HYPONATREMIA AND RISK OF SEVERE NEC (PAPER IV) 
Eighty-nine patients with verified NEC were identified as described in Paper I. Since no data 
on plasma sodium were found for one patient, only eighty-eight infants were included in the 
study. Median gestational age was 26.2 (range 23-38.4) weeks, 60 out of 88 patients were 
extremely preterm infants and 57 out of 88 male. Fifty-four infants had severe NEC and 34 had 
non-severe NEC. Infants who developed severe NEC had a younger postnatal age at NEC onset 
than those who had non-severe NEC, but this difference was attenuated when infants with 
pneumoperitoneum were excluded. For infants with severe NEC, median time to surgery or 
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death from NEC onset was 1 day (IQR 0-2). Hyponatremia was very common in both severe 
and non-severe NEC, but P-Na at NEC onset was significantly lower in the severe NEC group 
(130 vs 134.5 mmol/L, p=0.0016). Platelet counts were lower in the severe NEC group and 
plasma lactate concentration was slightly higher. The lactate difference was even higher in the 
sub-analysis excluding infants with pneumoperitoneum. P-Na before NEC onset did not differ 
between the two groups. We assessed the odds ratio of developing severe NEC with a 
generalized linear model analysis. Infants with hyponatremia had a higher odds ratio of 
developing NEC compared with those with normal P-Na (crude OR 3.91, 95% CI 1.52-10.04, 
p=0.005). Our results also showed that the more the plasma sodium had dropped at NEC onset, 
the higher the odds ratio of developing severe NEC (crude OR 1.19, 95% CI 1.07-1.33, 
p=0.002). Adjusted odds ratios for corrected gestational age and creatinine value were still 
significant. The sub-analysis excluding infants with pneumoperitoneum showed that infants 
with hyponatremia had an even higher odds ratio of developing NEC compared with those with 
normal P-Na (crude OR 23.0, 95% CI 2.78-190.08, p=0.004, adjusted OR 21.8, 95% CI 2.52-
188.03, p=0.005). This positive association was still consistent for the sodium difference (ΔNa 
crude odds ratio 1.24, 95% CI 1.07-1.43, p=0.004, adjusted OR 1.24, 95% CI 1.06-1.43, 
p=0.005) in this subgroup. Because extremely preterm newborns were more likely to have pre-
existing hyponatremia (40% vs 21%, p=0.087), we controlled if our findings were still 
consistent in this subgroup and found that the hyponatremia crude OR was 4.27 (95% CI 1.34-














6.1 THE EFFECT OF GESTATIONAL AGE (PAPER I) 
Extremely preterm infants show a different clinical and radiological presentation of NEC 
compared with more mature infants, often failing to present features known to be typical for 
NEC, such as pneumatosis intestinalis and bloody stools. Our findings show that the neonatal 
intestine´s response to NEC seems to be affected by the degree of intestinal maturity.  In this 
cohort, extremely preterm neonates represent two thirds of NEC cases and 74% of the surgical 
NEC cases. As expected, extremely preterm infants developed NEC symptoms at an older 
postnatal age compared with the more mature neonates (19, 93). Many factors can explain this; 
the differences in immunity maturity, the small volume of trophic feeding, the delayed 
microbial colonization of the intestine, and the use of broad spectrum antibiotics (1). 
IUGR/SGA was more common in the late preterm-term group. As has been previously 
discussed, term NEC more often occurs in infants with pre-existing risk factors. Bloody stools, 
a sign of colitis, is three times more frequent in the late preterm-term group than in the 
extremely preterm group, as already described by other authors (93, 97). The delayed gastric 
emptying, longer transit of nutrients, and reduced bowel motility are possible reasons for the 
fact that NEC-colitis is rarely seen in the most preterm infants (94, 197). Extremely preterm 
infants more often present with signs of ileus or sub-ileus, such as bilious gastric aspirates, 
feeding intolerance and a gasless abdomen. Gasless abdominal radiographs are actually quite 
common in the smallest infants with surgical NEC. Studies concerning neonatal intestinal 
motility patterns have shown that preterm infants react to feeding with decreased motor activity 
(called an immature response), resulting in a less efficient propulsion of nutrients from 
stomach to colon (94). At the radiographs, the extremely preterm group had a lower rate of 
pneumatosis intestinalis compared with the late preterm-term group, even considering that 
pneumatosis intestinalis was actually a requirement for medical NEC in order to be included in 
this cohort. This difference still remains significant in the surgical NEC subgroup. Pneumatosis 
intestinalis is caused by bacterial fermentation within the bowel wall and is a transient sign of 
bacterial translocation (109, 110). Extremely preterm infants have thin immature bowel walls, 
immature tight junctions and tend to receive small volumes of trophic feeds for several days 
(93, 198, 199). Considering the low sensitivity of plain abdominal radiographs it comes as no 
surprise that this radiological sign is more difficult to detect in this particular group (93, 200). 
On the other hand, the presence of large amounts of nutrients in the bowel leading to bacterial 
fermentation in the more mature infants likely accounts for the presence of pneumatosis 
intestinalis as a radiological sign of NEC in this group (93). Half of the infants who required 
 
44 
surgical intervention did not present with pneumoperitoneum at the radiographs. The fact that 
failing medical treatment was the relative indication for surgery in these cases highlights how 
challenging the decision to operate on NEC patients can be. Considering that more than 40 
years have passed since Bell et al described the clinical stages of NEC (11) it is hardly 
surprising that the NEC patient population has changed. The lack of specific signs of NEC in 
extremely preterm infants makes early diagnosis, especially in this group which currently 
represents the majority of NEC patients, clearly problematic. Acknowledging this fact evokes 
two thoughts; first, so far, prevention is probably the best strategy to reduce NEC consequences 
and, second, we need to be better equipped to identify infants who require surgical treatment. 
6.2 LOW SPLANCHNIC OXYGENATION AND RISK OF NEC (PAPER II) 
In Paper II we tested if NIRS could be helpful in the identification of extremely preterm infants 
with impaired splanchnic perfusion and therefore at high risk of developing NEC. We found 
that low mean splanchnic oxygenation (SrSO2 <30%) in the first week of life is associated with 
an increased risk of developing NEC in extremely preterm newborns receiving enteral 
nutrition. The regulation of bowel perfusion in neonates changes over time and initially 
depends mainly on oxygen demands (76, 201). Nowadays, splanchnic microcirculation 
impairment and enteral nutrition are acknowledged to be important factors in the pathogenesis 
of preterm NEC (64, 75, 83).  Several studies have assessed NIRS as a non-invasive tool for 
the continuous monitoring of splanchnic oxygenation as a measure of intestinal perfusion in 
preterm infants (158, 202, 203). Kuik et al reported that preterm infants with both low 
gestational and postmenstrual age were not able to increase their splanchnic oxygenation after 
bolus feeding, which was postulated to be essential in order to meet metabolic demands (204). 
Our data show that the risk ratio of developing NEC is significantly higher in infants with one- 
hour mean SrSO2 <30% during enteral feeding in the first week of life. In accordance with our 
results, other authors have reported lower SrSO2 in infants who develop NEC or feeding 
intolerance compared with those who did not (80, 160). This positive association was even 
stronger when adjusted for gestational age. We had fewer infants born in weeks 26 and 27 of 
gestation in our cohort than expected, and a selection bias could not be ruled out. In order to 
see if our results were still consistent, we performed a sub-analysis excluding infants born at 
GA 26 and 27 weeks and we found a significant correlation between mean SrSO2 < 30% and 
risk of NEC. In our cohort, all infants who developed NEC had been fed more than 60 ml/kg/d, 
making enteral feeding an important confounder. In a sub-analysis of this subgroup, we did not 
find any other explanatory variable that could increase the risk of NEC, except mean SrSO2 
<30% and mean SrSO2 as a continuous variable. Extremely preterm infants are constantly 
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under stress and feeding causes an increased metabolic demand. It has also been shown that 
continuous enteral nutrition does not increase SrSO2, as bolus feeding does (205, 206). We 
postulated that low mean SrSO2 values in the NEC group could be the expression of the 
maximal oxygen extraction in a very immature bowel. This could explain why only those 
infants fed more than 60 ml/kg/d with mean SrSO2 <30% during the first days of life developed 
NEC while those fed with smaller amounts did not. The local autoregulatory control of 
intestinal blood flow does not mature until the fifth week after birth (204, 207). An alternative 
explanation could be that those infants who are already fed more than 60 ml/kg/d at day 4 
receive fortifiers earlier which contain cow`s milk proteins and increase milk osmolarity, which 
could be an extra trigger in the development of NEC (208, 209). Advancing enteral 
feed volumes at lower daily increments does not reduce the risk of NEC or death in extremely 
preterm newborns, but most studies do not include the very first days of life (35, 210). 
Monitoring splanchnic oxygenation with NIRS might help the clinician to individualize enteral 
feeding advancement in the very first days and identify those who are at the highest risk of 
NEC early. 
6.3 INDICATION FOR SURGERY IN SEVERE NEC (PAPERS III AND IV)  
The decision to operate on a critically ill extremely preterm infant can be frightening, but 
early intervention on the necrotic bowel does give the infant a better chance of survival 
without major complications. Early diagnosis of bowel necrosis is probably the key to 
improving the long-term outcomes of NEC patients by promoting an earlier transfer to 
surgical centers and surgery, possibly resulting in salvage of viable bowel (166). In the best 
case scenario, surgical intervention would occur in infants with irreversible intestinal 
ischemia, prior to the occurrence of bowel perforation (166, 211). Predicting the progression 
of bowel inflammation to necrosis and the identification of NEC infants who ultimately will 
require surgical intervention is very difficult, especially in extremely preterm infants (211, 
212). When there is radiographic evidence of pneumoperitoneum it may already be too late 
and actually this sign is not always present in the case of bowel ischemia (95, 99, 213). In 
Paper I, we showed that almost 50% of the NEC infants who required surgery did not present 
with pneumoperitoneum on the plain abdominal radiography. Thus, clinical deterioration 
despite optimal medical care often becomes a relative indication for surgical treatment, but 
the timing is still a challenge (165, 166). Many factors can be helpful in the decision-making 
for surgical intervention.  
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In Paper III, we found that the sonographic finding of complex fluid collections was associated 
with the need for surgery. Complex fluid collections are a sign of intraperitoneal fluid with 
debris levels and septa, which may represent a sign of peritonitis, intestinal necrosis and 
sometimes occult bowel perforation (104, 124, 200).  This finding is in accordance with the 
current literature (120, 200, 214) and complex fluid collections have been suggested as an 
indication for surgery in the latest review (121). No significant association was found between 
absent bowel flow and need of surgery or adverse outcome in our population. However, only 
infants who required surgical treatment presented with absent bowel perfusion at the abdominal 
sonography. Faingold et al (119) were the first to report the correlation between bowel necrosis 
and absence of bowel perfusion at the Doppler sonography. In our study, the small number of 
patients studied and the fact that patients in our unit are often mechanically ventilated with high 
frequency oscillatory ventilation (HFOV) can have masked this correlation; the HFOV 
oscillations generate Doppler-artefacts at the slowest Doppler velocity making the assessment 
of the intestinal perfusion very difficult. It is possible that we failed to detect absent bowel 
perfusion in some infants. Absence of peristalsis, free fluid and bowel wall thinning at the AUS 
were not specific signs of bowel necrosis and were not related to our outcomes, even though 
these signs were more often present in the population who required surgery. The important role 
of abdominal ultrasound in the diagnosis and management of NEC is now well acknowledged 
(120, 121, 126), especially in situations where abdominal radiology is not conclusive.  
In Paper IV our main finding was that hyponatremia and/or a sudden decrease in plasma sodium 
at the onset of NEC is associated with an increased odds ratio for severe intestinal inflammation 
or ischemia, especially in infants without pneumoperitoneum. We found that for each mmol in 
plasma sodium decrease at the onset of NEC, the odds ratio for severe NEC increases by 1.2. 
We wanted to draw attention to infants who are going to require surgery, because they carry 
the highest mortality and long-term morbidity. Severe hyponatremia or a sudden decrease in 
plasma sodium could be an early predictor for the failure of conservative treatment in infants 
with NEC. These findings are in accordance with Tepas et al (135) who described 
hyponatremia as one of the metabolic derangements to consider when timing surgery in NEC 
patients. Since hyponatremia is a common condition in preterm infants from the second week 
of life, we also focused on the decrease in plasma sodium from the level when the infants were 
in a clinically stable condition. Hyponatremia has been studied as a predictor of tissue ischemia 
in different surgical conditions (215-219). The exact etiology of hyponatremia in surgical 
conditions is not well understood. Both hypovolemia and severe inflammation could result in 
the activation of arginine-vasopressin (AVP) production resulting in water retention and 
hyponatremia (215, 217). Recent studies show that proinflammatory cytokines may regulate 
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AVP secretion and the development of hyponatremia (220). P-Na is easily obtained and may 
often serve as a bedside analysis, available around the clock in all kinds of neonatal units. To 
know that a greater decrease in P-Na corresponds to an increased risk of severe NEC at NEC 
onset can be helpful in the clinical management of NEC infants. This is true even for extremely 
preterm infants where hyponatremia is very common. We decided to exclude infants with 
pneumoperitoneum in Paper III and perform a sub-analysis in Paper IV for two reasons; first, 
to exclude cases with misdiagnosed spontaneous intestinal perforation, since SIP has another 
etiology and, second, because pneumoperitoneum is the universally accepted indication for 
surgery (95, 221). 
6.4 LIMITATIONS 
The major limitation throughout this thesis is the small number of patients.  This is of course 
an issue with power, increasing the probability of failing to reject our null hypothesis when 
false (a type II error). For instance, in Paper III, absent Doppler flow at the abdominal 
ultrasound was not associated with a need for surgery as reported by other authors, probably 
because of the small number of patients. In Papers I, III and IV we decided to use validated 
cases of NEC and not just register data, which would easily have increased the sample size, 
because of the issues related to the definition and classification of NEC (222, 223). 
Reviewing medical case records is time consuming, but we wanted to keep the dataset as 
“clean” as possible from spontaneous intestinal perforation and other acquired intestinal 
diseases (98). In order to avoid including patients without NEC, we excluded all those with 
suspected medical NEC who did not have a radiological validation of the disease. We might 
have therefore excluded medical NEC that did not show radiological signs and, therefore, 
were considered uncertain. This can explain the numerical imbalance between surgical and 
medical NEC in this dataset. Bell´s staging system was used to validate the NEC cases 
because at the time (and still today), it was the most commonly used in the literature. One 
might argue that Bell´s staging system was actually not meant for case definition (11), that it 
is not really appropriate with a changing NEC population and that it increases the risk of 
misdiagnosing SIP for NEC (13, 223). It remains, however, the most used system. The 
retrospective design is of course a limitation in Papers I, III, and IV. The retrospective design 
is the reason why we decided not to study the accuracy (specificity and sensitivity) of 
abdominal ultrasound in NEC patients. To avoid bias (especially selection or verification 
bias) the study of accuracy of a diagnostic test should be prospective, and where a standard 
protocol is strictly followed. On the other hand, patients were consecutive and we collected 
the data prospectively and when this was not possible (as in Paper IV, where NEC cases were 
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already defined), an independent, second researcher collected the data, for instance on plasma 
sodium. In Paper II we were not able to invite and include consecutively all the extremely 
preterm infants born during the study period because, at the time, there were several ongoing 
clinical studies in our institution addressing the same study population. Missing data on 
specific variables, such as plasma glucose in Paper IV is, of course, a limitation. Because of 
missing data, plasma glucose was excluded from our model. In Papers II and IV all the 
analyses performed are complete case analyses. 
There are many limitations related to NIRS measurements and technology. Short and not-
repeated measurements as well as the presence of artefacts are the two most important ones. 
The presence of artefacts due to movements, air and stools may have had an impact on the 
interpretation of the data. We opted for short measurement durations because it was easier to 
ensure the quality of the SrSO2 in the smallest infants and to better estimate when artefacts 
were caused by movements. An attempt to compensate for artefacts was to adjust for the first 
passage of stool, because meconium contains substances with a chromophoric effect (224).  















The population of NEC patients has changed over time and our findings suggest that the clinical 
and radiological presentation of NEC depends on gestational age. We believe that the findings 
in this thesis might help to identify infants with bowel necrosis, especially when the 
radiological sign of pneumoperitoneum is not present. 
• Extremely preterm neonates with NEC do not show the specific clinical and 
radiological signs of NEC, which can result in doctor's delay for both medical and 
surgical treatment. 
• In order to identify extremely preterm infants with a high risk of NEC early, we tested 
monitoring splanchnic oxygenation during the first week of life. A mean low 
splanchnic oxygenation during enteral nutrition seems to be associated with a higher 
risk of developing NEC in extremely preterm infants. Validation in a larger cohort is 
therefore needed. 
• To help in the decision to intervene surgically, abdominal ultrasound might be a 
useful tool. Our study found that the sonographic finding of complex fluid collections 
was associated with the need for surgery.  
• Hyponatremia and/or a decrease in plasma sodium at the onset of NEC is associated 















8 FUTURE PROSPECTIVES 
NEC has been far from being completely understood and the clinical management probably 
needs an update. The future NEC staging system should consider the different clinical 
presentations in infants with different gestational ages and should include abdominal 
ultrasound in the standard care, as Gordon already suggested in the “two out of three rule” (101, 
103, 104, 109, 119, 225). The validation of our findings in the NIRS study in a larger cohort is 
our next step. We began a collaboration with University Medical Center Groningen, the 
Netherlands, for a validation of low splanchnic oxygenation as an early marker of impaired 
microcirculation in order to identify infants who will develop NEC. We think the 
microcirculation has an important role in the progression of NEC as well.  
The emergent technique of Remote Ischemic Conditioning has proven to be helpful in 
containing the progression of intestinal inflammation and ischemia in animal models (226, 
227). In collaboration with Sick Kids in Toronto, where these experimental studies have been 
performed, we are going to start a pilot study on preterm infants with NEC to assess if remote 

















9 SUMMARY IN SWEDISH 
Nekrotiserande enterokolit (NEC) är en allvarlig tarmsjukdom som framför allt drabbar för 
tidigt födda barn. Tillståndet kan ge allt från ytliga slemhinneskador med inflammation och 
svullnad till perforation av tarmen. Trots årtionden av forskning saknas fortfarande avgörande  
landvinningar som påtaglig förbättrarar överlevnaden och minskar de långsiktiga 
konsekvenserna av NEC. Orsaken till sjukdomen är ännu inte klarlagd. Omogen 
tarmimmunitet, nedsatt tarm-cirkulation, enteral näringstillförsel och onormal bakterieflora i 
tarmen är sannolikt viktiga bidragande orsaker. Genom åren har NEC-populationen förändrats 
med en ökande andel extremt prematura barn. Vanlig slätröntgen av buken anses vara det bästa 
metoden för bilddiagnostik vid NEC. Dessvärre är slätröntgen inte en tillräckligt specifik metod 
och flera barn riskerar att behandlas för sent med allvarliga konsekvenser för tarmfunktionen 
som följd. Det gör att beslutet om och när ett kirurgiskt ingrepp är nödvändigt fortfarande är 
mycket utmanande. Preliminära studier har visat att ultraljud på tarmen kan upptäcka NEC 
tidigare än enbart slätröntgen. 
Det övergripande syftet med detta projekt var att beskriva de för tidigt födda barn som riskerar 
att utveckla NEC och hur de som utvecklar svår NEC och behöver kirurgisk behandling kan 
identifieras tidigt med hjälp av ny bilddiagnostik. 
Syftet med arbete I var att beskriva skillnaden i den kliniska och radiologiska bilden vid NEC 
hos extremt prematura barn jämfört med mer mogna barn. Extremt prematura barn visar inte 
typiska tecken på NEC, såsom blodig avföring eller intramural gas på röntgen. 
Syftet med arbete II var att bedöma abdominell syresättning under enteral näringstillförsel hos 
extremt tidigt födda barn. Abdominell syresättning mäts tack vare infraröd spektroskopi (“Near 
Infrared Spectroscopy: NIRS). Med hjälp av en liten sensor kan NIRS detektera 
blodflödesförändringar i djupare vävnader och beskriver på så sett tarmcirkulationen.  Låg 
genomsnittlig abdominell syresättning, mindre än 30%, under den första levnadsveckan var 
förknippad med en ökad risk att utveckla NEC. 
Syftet med arbete III var att avgöra om det finns en korrelation mellan ultrasljudsfynd och 
sämre kliniska utfall, definierade som kirurgi eller död. Nyfödda med radiologiskt och / eller 
histopatologiskt bekräftad nekrotiserande enterokolit, genomgick ultraljud av buken. 
Komplexa vätskesamlingar i buken korrelerade starkt med behovet av kirurgi hos spädbarn 
med svår NEC. 
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Syftet med arbete IV var att bedöma om hyponatremi, eller försämring av redan befintlig 
hyponatremi, i samband med debut av nekrotiserande enterokolit var associerat med 
operationskrävande tarminflammation och ischemi alternativt ledde till död. Hyponatremi och 
en plötslig minskning av plasmanatriumkoncentrationen vid insjuknandet i NEC kan vara 
användbara markörer för svår tarminflammation/ischemi där ett överhängande behov av 
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